CClinicalTrials.gg
RecruitingNCT06578065Updated Sep 9, 2026

Colorectal Anastomosis Outcomes Using the Novel Powered Circular Stapler Compared With Manual Circular Staplers.

An interventional study of Echelon Circular™ Powered Stapler and 2-row circular staplers manual in Colorectal Anastomosis, sponsored by Fundación para la Investigación del Hospital Clínico de Valencia. Recruiting at 4 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Fundación para la Investigación del Hospital Clínico de Valencia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
540
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients whom meet all eligibility criteria will be assigned random 1:1 to one of the following arms:

  • ECPS group: Echelon Circular™ Powered Stapler (n=270)
  • MCS Group: manual circular staplers (n=270) Patients will be followed during 30 days in order to evaluate the primary endpoint.
Read the detailed description

Anastomotic Leakage (AL) is the complication that most concerns colorectal surgeons. It leads to prolonged postoperative stay, increased costs, risk of reoperations and a permanent colostomy, together with an increase in morbidity and mortality.

The novel Echelon Circular™ Powered Stapler (ECPS) (Ethicon, Somerville, NJ, USA), introduces design changes that could decrease the rate of technical errors and improve clinical outcomes. The powered stapler decreases the force needed on firing the device, improving stability at the anastomotic site. Atraumatic Gripping Surface Technology reduces the compressive forces on tissues, and along with 3D Stapling Technology allows a better compression distribution throughout the anastomosis and a better hemostasis.

This is a multicenter, randomized, open-label, controlled with parallel groups clinical trial, with 8 participant sites in total (4 sites in Spain and 4 sites in France), to include an approximate sample size (n) of 570 patients who will undergo a colorectal anastomosis after Hartmann reversal, left colectomy, sigmoidectomy or anterior rectal resection, for benign or malignant pathology.

540 patients assigned randomly 1:1 to assess whether technical improvements of Echelon Circular™ Powered Stapler (ECPS) have an impact on left-sided colorectal Anastomotic Leakage (AL) rate compared to current manual circular staplers (MCS).

Anastomosis could be performed open, laparoscopically or with robotic assistance.

After surgery, patients will be followed during 30 days in order to evaluate the primary endpoint.

02

Conditions studied

  • Colorectal Anastomosis
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient or its legal representative informed consent.
  • Age ≥ 18 years.
  • Patients who will undergo a colorectal anastomosis after left colectomy, sigmoidectomy or anterior rectal resection, for benign or malignant pathology (NOTE: Hartmann reversal cases also included).

Exclusion criteria

Exclusion Criteria:

  • Diverting stoma.
  • Emergency surgery.
  • American Society of Anaesthesiologists (ASA) score ≥ IV.
  • Transanal total mesorectal excision approach.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
540 participants (estimated)

Study arms

  • Experimental
    ECPS group

    Echelon Circular™ Powered Stapler

    Device: Echelon Circular™ Powered Stapler

  • Active comparator
    MCS Group

    2-row circular staplers manual

    Device: 2-row circular staplers manual

Interventions

  • DeviceEchelon Circular™ Powered Stapler

    Echelon Circular™ Powered Stapler will be used in colorectal anastomosis.

  • Device2-row circular staplers manual

    2-row circular staplers manual will be used in colorectal anastomosis.

05

What researchers measure

Primary outcomes

  1. Anastomotic leakage rates differences between both groups at 30 postoperative days

    To assess whether ECPS have an impact on left-sided colorectal AL rate compared to current manual circular staplers (MCS).

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Postoperative endoluminal bleeding rate differences between both groups.

    To assess whether ECPS improve haemostasis in the anastomotic line

    Time frame: Through study completion, an average of 1 year

  2. Morbidity differences between groups according to the Clavien-Dindo classification.

    To evaluate whether ECPS have an impact in postoperative morbidity

    Time frame: Through study completion, an average of 1 year

  3. Re-intervention rate differences between both groups

    To evaluate whether ECPS have an impact in re-interventions rate

    Time frame: Through study completion, an average of 1 year

06

Study locations

3 of 4 sites recruiting
  • Consorci Corporació Sanitària Parc Taulí de Sabadell
    Sabadell, Barcelona 08208, Spain
    Not yet recruiting
  • Hospital General Universitario Gregorio Marañón
    Madrid, 28007, Spain
    Recruiting
  • Hospital Clínico Universitario Virgen de la Arrixaca
    Murcia, 30120, Spain
    Recruiting
  • Hospital Clínico Universitario de Valencia
    Valencia, 46010, Spain
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06578065
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Responsible party
Sponsor
First posted
Aug 29, 2024
Start date
Jun 27, 2024
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Vicente Pla Martí
Contact
vplamarti@yahoo.es
+34 669204303

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion